Skip to main content
Clinical Trials/DRKS00030380
DRKS00030380
Recruiting
未知

One-piece zirconia implants restored with three-unit all-ceramic fixed dental prostheses on maxillary and mandibular posterior teeth. A prospective clinical multicentric study. - PROSEC Multicentric Study

Charité Campus Benjamin Franklin0 sites40 target enrollmentOctober 10, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
ICD-10-GM K10. 9Bone quality: 1, 2, 3 or 4 according to Lekholm & Zarb.Bone quantity: A-E according to Lekholm & Zarb.Papilla index (Jemt)Modified Plaque Index (mPI)(Mombelli et al.)Modified Sulcular Bleeding Index (mBI) (Mombelli et al.)Probing depth (PD), mmClinical attachment level (CAL), mm
Sponsor
Charité Campus Benjamin Franklin
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Charité Campus Benjamin Franklin

Eligibility Criteria

Inclusion Criteria

  • Patients with the following planning findings are restored with implants:
  • \- The intraoral condition of the patient shows a dentition with the need for a three\-unit end abutment bridge.
  • \- Internal sinus lift up to 2mm allowed.
  • \- Min. implant length 8mm.
  • \- Extraction at least 3 months ago. Only early implant placement (3 \- 6 months post extraction) and late implant placement (\> 6 months post extraction).
  • \- Lateral bone augmentations are possible simultaneously during the surgical procedure.
  • \- The patient demonstrates good oral hygiene and compliance.
  • \- A pre\-implant hygiene phase and or pa treatment must be completed.

Exclusion Criteria

  • \- Persons under 18 or persons lacking legal capacity.
  • \- Untreated acute periodontitis with pocket depths \> 4 mm.
  • \- Heavy smokers (more than 10 cigarettes per day).
  • \- Taking bisphosphonates or rank ligand inhibitors (Denuso\-map) or other drugs affecting bone metabolism (e.g. Cor\-tison).
  • \- Pregnant women.
  • \- Alcohol or drug abusers.
  • \- Patients with an infectious disease such as hepatitis or HIV or AIDS.
  • \- Patients with severe, uncontrolled diabetes.
  • \- Immediate implantations.
  • \- Patients with signs of bruxism.

Outcomes

Primary Outcomes

Not specified

Similar Trials